Doctors in Europe, Australia, and Canada have been using intestinal ultrasound (or point-of-care ultrasound) for decades to help improve patient education and management of inflammatory bowel disease. However, the technology has only recently gained traction in the United States. In a new Q&A, Jill Gaidos, MD, associate professor of medicine (digestive diseases) and medical director of the Yale Inflammatory Bowel Disease Program, discusses how intestinal ultrasound enhances patient care, supports physician education, and enables research.
In a Q&A, Yale School of Medicine's Shana Gleeson, MD, discusses the risk of infection among transplant recipients, common and opportunistic infections, and how infectious diseases connect us all.
While esophageal cancer is not as common as some cancers, it’s important to be familiar with the common conditions associated with it, including acid reflux, gastroesophageal reflux disease (GERD) and obesity.
The Yale School of Medicine and Yale Health Sciences IT Educational Technology & Innovation team hosted its inaugural event, a one-half day Ideathon, which sparked innovative technological solutions to medical education challenges.
The Department of Internal Medicine is pleased to welcome the following new staff, faculty, postdoctoral fellows, and postdoctoral associates who joined the team in March 2025.
Understanding and categorizing the various types of tubulointerstitial responses in acute kidney injury (AKI) may lead to the development of new treatments for the condition, according to Yale School of Medicine researchers who published a review in The Journal of Clinical Investigation on March 17.
Meet Yale School of Medicine clinical fellow Spyridon Ntelis, MD, who chose the Yale Endocrinology Fellowship program because of its broad clinical training and the opportunity to work with dedicated, world-renowned faculty
Clinical trials are elemental to cancer research as the critical link between laboratory science and patients, the highly-controlled meeting of a treatment and a disease, sometimes for the first time.Yale Cancer Center’s clinical trial office is led by two people with five decades of experience between them in this specialized realm of cancer treatment. Director of the Clinical Trials Office (CTO) Ian Krop, MD, PhD, began as a cancer researcher in the lab and transitioned to clinical trials about 25 years ago because he wanted to more directly impact patients. Alyssa Gateman MPH, executive director of the CTO, has worked with cancer researchers and clinical trial specialists, as well as data and compliance to ensure patient protection over the last 25 years.
Yale School of Medicine's Florence Hsu, MD, assistant professor of medicine (rheumatology, allergy and immunology), discusses the role of mast cells in allergies.